Ledipasvir/sofosbuvirTreatment failure secondary to the development of drug resistance in mixed hepatitis C virus infection: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1655卷 / 1期

关键词：

D O I：

10.1007/s40278-017-31231-2

中图分类号：

学科分类号：

摘要：

引用

页码：152 / 152

共 50 条

[1] Ledipasvir/sofosbuvirTreatment failure: case report
[J]. Reactions Weekly, 2021, 1836 (1) : 453 - 453
[2] Ledipasvir/sofosbuvirTreatment failure: case report
[J]. Reactions Weekly, 2020, 1822 (1) : 177 - 177
[3] Ledipasvir/sofosbuvir/vonoprazanRecurrence of hepatitis C virus secondary to treatment failure: case report
[J]. Reactions Weekly, 2016, 1630 (1) : 154 - 154
[4] Ledipasvir/sofosbuvir/omeprazole interactionDevelopment of antiviral resistance and treatment failure in hepatitis C infection: case report
[J]. Reactions Weekly, 2019, 1750 (1) : 162 - 162
[5] Ledipasvir/sofosbuvirDevelopment of resistance in hepatitis C virus infection genotype 4d: case report
[J]. Reactions Weekly, 2018, 1722 (1) : 202 - 202
[6] Daclatasvir/sofosbuvirVirologic failure due to development of drug resistance in hepatitis C virus infection: 2 case reports
[J]. Reactions Weekly, 2020, 1833 (1) : 145 - 145
[7] Ledipasvir/sofosbuvirReactivation of occult hepatitis B virus infection: case report
[J]. Reactions Weekly, 2017, 1647 (1) : 182 - 182
[8] Mixed cryoglobulinemia secondary to hepatitis C virus infection
Agnello, V
Romain, PL
[J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1996, 22 (01) : 1 - +
[9] Daclatasvir/ledipasvir/sofosbuvirDevelopment of resistance in hepatitis C virus genotype 4 infection: 2 case reports
[J]. Reactions Weekly, 2019, 1734 (1) : 169 - 169
[10] Posaconazole/voriconazoleTreatment failure secondary to development of drug resistance: case report
[J]. Reactions Weekly, 2019, 1752 (1) : 331 - 331

← 1 2 3 4 5 →